Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PWIB123on May 27, 2021 10:42am
72 Views
Post# 33275273

RE:RE:RE:RE:RE:More volume/higher valuation? This is how to get there.

RE:RE:RE:RE:RE:More volume/higher valuation? This is how to get there.I feel the same way.  It's the radio silence and lack of energy around the stock that is the hardest to wait out, especially when you see the selling, day after day after day.  I liken our insatiable desire for new news, anything, just a taste of what is to be, to a drug addict.  Everyone needs/wants just a little something to keep them content and going a little longer before completely giving in and up.  THTX has to also recognize this is reality.  

In my mind, there are enough clues to sit tight and wait for the company to do what they said they are going to do.  Hopefully, they'll begin to make time to start filling in marketing gaps while they operationalize the business, but it still feels like they are in a major paradigm shift as it relates to the company's future.  I don't know if we are giving them enough credit for what's happening behind the scenes, but it sure would be better if they could manage that and the concerns addressed here simultaneously.

I haven't been around as long as some of you, but I'm still upside down on my investment, and I intend to see this prospect through to the end.  I just can't see how major announcements coming soon don't start to get picked up and recognized regardless of what could be happening now.  I'm betting on something really special happening here.
<< Previous
Bullboard Posts
Next >>